Tulane University: FDA-backed Metric Used to Determine Effectiveness of Rectal Cancer Drugs May Be Unreliable, Says Study
July 19, 2025
July 19, 2025
NEW ORLEANS, Louisiana, July 19 (TNSjou) -- Tulane University issued the following news release:
* * *
An FDA-backed metric used to determine effectiveness of rectal cancer drugs may be unreliable, says new study
A new study by a Tulane University researcher casts doubt on a widely used shortcut in rectal cancer drug trials, raising concerns that some treatments may be fast-tracked for approval without evidence they help patients live longer.
. . .
* * *
An FDA-backed metric used to determine effectiveness of rectal cancer drugs may be unreliable, says new study
A new study by a Tulane University researcher casts doubt on a widely used shortcut in rectal cancer drug trials, raising concerns that some treatments may be fast-tracked for approval without evidence they help patients live longer.
. . .